Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02771262 · ClinicalTrials.gov registry record
Making Sense of Dyspnea Assessment
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 148
- Enrollment target
NCT02771262 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 148 participants.
The verdict
NCT02771262 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 148 participants
- Enrollment target
Study Summary
Dyspnea, or uncomfortable labored breathing, is an important patient-reported outcome (PRO). It is the primary and most disabling symptom of chronic obstructive pulmonary disease (COPD). There is a high priority to improve dyspnea PRO assessment and predict exacerbations. Frequent exacerbations are associated with increased disability, decreased quality of life (QOL), and accelerated lung function decline. Goals: To test the relative sensitivity to change, responsiveness and predictive validity of a comprehensive dyspnea outcome computer adaptive test (CAT) that measures new anxiety and activity avoidance domains and is more efficient to administer than existing dyspnea scales. Expected Outcomes: Investigators expect to: 1. begin to transform how dyspnea is assessed; 2. improve dyspnea symptom management; 3. impact functional status; 4. improve QOL; 5. facilitate the earlier treatment and prevention of exacerbations; 6. improve COPD prognosis and survival; and 7. improve COPD healthcare utilization.
Interventions
- OTHER Pulmonary Rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02771262
The ClinicalTrials.gov registry entry for NCT02771262 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulmonary Rehabilitation is the first listed.
NCT02771262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02771262 about?
NCT02771262 is a clinical study titled "Making Sense of Dyspnea Assessment". Dyspnea, or uncomfortable labored breathing, is an important patient-reported outcome (PRO). It is the primary and most disabling symptom of chronic obstructive pulmonary disease (COPD). There is a high priority to improve dyspnea PRO assessment and predict exacerbations. Frequent exacerbations are ...
What is the current status of trial NCT02771262?
This trial is currently completed. The enrollment target is 148 participants. The study started on 2014-10. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT02771262?
The interventions under investigation include: Pulmonary Rehabilitation (OTHER).
Who is sponsoring clinical trial NCT02771262?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.